Get started
Author

Kimberly Peihsi Ku

Platelets Promote Metastasis via Binding Tumor CD97 Leading to Bidirectional Signaling that Coordinates Transendothelial Migration
2018 · Yvona Ward, Ross Lake, et al. · Cell Reports · 165
Multidisciplinary clinic approach improves overall survival outcomes of patients with metastatic germ-cell tumors
2017 · C. Albany, N. Adra, et al. · Annals of Oncology · 84
VIOLIN: vaccine investigation and online information network
2007 · Z. Xiang, T. Todd, et al. · Nucleic Acids Research · 82
PDF
Retrospective evaluation of colistin versus tigecycline for the treatment of Acinetobacter baumannii and/or carbapenem-resistant Enterobacteriaceae infections
2012 · Kimberly Ku, Jason M. Pogue, et al. · American Journal of Infection Control · 78
Appetite Responds to Changes in Meal Content, Whereas Ghrelin, Leptin, and Insulin Track Changes in Energy Availability
2009 · Katarina T. Borer, Elizabeth Wuorinen, et al. · The Journal of Clinical Endocrinology & Metabolism · 69
PDF
Comparison of the Clinical Characteristics and Outcomes Associated with Vancomycin-Resistant Enterococcus faecalis and Vancomycin-Resistant E. faecium Bacteremia
2012 · Kayoko Hayakawa, Dror Marchaim, et al. · Antimicrobial Agents and Chemotherapy · 59
The burden of multidrug-resistant organisms on tertiary hospitals posed by patients with recent stays in long-term acute care facilities
2012 · Dror Marchaim, Teena Chopra, et al. · American Journal of Infection Control · 59
Treatment of Methicillin-Resistant Staphylococcus aureus Infections with a Minimal Inhibitory Concentration of 2 μg/mL to Vancomycin: Old (Trimethoprim/Sulfamethoxazole) versus New (Daptomycin or Linezolid) Agents
2012 · Michelle L Campbell, Dror Marchaim, et al. · Annals of Pharmacotherapy · 45
SWOG/NRG S1914: Randomized phase III trial of induction/consolidation atezolizumab + SBRT versus SBRT alone in high risk, early-stage NSCLC.
2025 · Charles B. Simone, Megan Eileen Daly, et al. · Journal of Clinical Oncology · 23
Cotton Fever: A Condition Self-Diagnosed by IV Drug Users
2016 · A. M. Zerr, K. Ku, et al. · The Journal of the American Board of Family Medicine · 13
PDF
Characterization of Recombinant B. abortus Strain RB51SOD Toward Understanding the Uncorrelated Innate and Adaptive Immune Responses Induced byRB51SOD Compared to Its Parent Vaccine Strain RB51
2011 · Jianguo Zhu, Charles B. Larson, et al. · Frontiers in Cellular and Infection Microbiology · 9
PDF
Survival outcomes of patients with metastatic germ cell tumor (mGCT) treated from 1998 to 2012: The Indiana University (IU) experience.
2016 · Nabil Adra, Kimberly Peihsi Ku, et al. · Journal of Clinical Oncology · 5
Intravascular large B-cell lymphoma presenting with altered mental status: A case report
2019 · Christopher Robert D’Angelo, Kimberly Ku, et al. · World Journal of Clinical Oncology · 4
Fruquintinib-Associated Posterior Reversible Encephalopathy Syndrome in a Patient With Multiply Metastatic Rectal Cancer
2024 · Caroline B. Ledet, Ugur Sener, et al. · Clinical Colorectal Cancer · 3
A retrospective analysis of patients with metastatic germ cell tumor (GCT) treated at Indiana University (IU) from 2000 to 2012.
2015 · Kimberly Ku, Samar Ibrahim, et al. · Journal of Clinical Oncology · 3
Induction and consolidation atezolizumab with stereotactic body radiation therapy versus radiation alone in high-risk, early-stage non-small-cell lung cancer (SWOG/NRG S1914): a multicentre, open-label, superiority, phase 3, randomised controlled trial
2026 · Megan E Daly, Charles B Simone, et al. · The Lancet · 1
Trop-2 expression on treatment resistant cancer cells in castrate-resistant prostate cancer (CRPC) as a predictive biomarker for targeted therapy.
2017 · Kimberly Peihsi Ku, Joshua Michael Lang, et al. · Journal of Clinical Oncology · 1
Volumetric Modulated Arc Therapy Decreases Incidence of Acute Rectal Toxicity in the Treatment of Low- and Intermediate-Risk Prostate Cancer
2012 · M. Dominello, K. Ku, et al. · International Journal of Radiation Oncology*Biology*Physics · 1
PDF
Treatment decision-making after CAR-T and bispecific antibody therapy in relapsed/refractory multiple myeloma: Real-world perspectives from U.S. hematologist/oncologists.
2026 · Sarah Hendry, Olivia Parry, et al. · Journal of Clinical Oncology
Tumor-specific drivers of PD-1/PD-L1 inhibitor brand preference in NSCLC, melanoma, and renal cell carcinoma: A U.S. oncologist perspective.
2026 · Olivia Parry, Kimberly Peihsi Ku, et al. · Journal of Clinical Oncology
Operational and clinical drivers of subcutaneous PD-1/PD-L1 inhibitor adoption: A mixed-methods analysis of U.S. oncology practice patterns.
2026 · Kimberly Peihsi Ku, Sarah Hendry, et al. · Journal of Clinical Oncology
P3.09.08 Tumor Treating Fields for Patients With Metastatic Non-Small Cell Lung Cancer: Real World First Experience
2025 · R. Kotecha, O. Gal, et al. · Journal of Thoracic Oncology
Axillary Needle Biopsy in the Era of American College of Surgeons Oncology Group (ACOSOG) Z0011: Institutional Experience With a Largely Urban Minority Population and Review of the Literature
2022 · Lydia Choi, Kimberly Ku, et al. · Cureus
PDF
Bone Marker Responses to Exercise Parameters: Relative Effectiveness of Mechanical,Temporal, and Hormonal Stimulation
2009 · Katarina Borer, KU Kimberly, et al. · Journal of Clinical Densitometry
Appetite Responds To Gastrointestinal Events While Ghrelin, Leptin, And Insulin Track Changes In Energy Availability
2009 · Katarina T. Borer, Elizabeth Wuorinen, et al. · Medicine & Science in Sports & Exercise
Works count: 25
Citation count: 704
H-index: 10
I10-index: 10
Year
Topic
Type